A detailed history of Menard Financial Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Menard Financial Group LLC holds 761 shares of LLY stock, worth $553,399. This represents 0.46% of its overall portfolio holdings.

Number of Shares
761
Previous 744 2.28%
Holding current value
$553,399
Previous $673,000 0.15%
% of portfolio
0.46%
Previous 0.5%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $13,126 - $16,320
17 Added 2.28%
761 $674,000
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $20,296 - $25,453
28 Added 3.91%
744 $673,000
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $424,015 - $567,272
716 New
716 $557,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $691B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.